|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/40 | (2006.01) |
| A61K 31/404 | (2006.01) | ||
| A61P 25/06 | (2006.01) | ||
| C07B 61/00 | (2006.01) | ||
| C07D 403/06 | (2006.01) |
| (11) | Number of the document | 1373254 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01271106.5 |
| Date of filing the European patent application | 2001-12-06 | |
| (97) | Date of publication of the European application | 2004-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2005-11-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2001/002338 |
| Date | 2001-12-06 |
| (87) | Number | WO 2002/050063 |
| Date | 2002-06-27 |
| (30) | Number | Date | Country code |
| 0031094 | 2000-12-20 | GB |
| (72) |
OGILVIE, Ronald J., Pfizer Global Res&Development, GB
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, GB |
| (54) | Process for the preparation of the anti-migraine drug eletriptan |
| Process for the preparation of the anti-migraine drug eletriptan |